Ark. Goes After J&J For Risperdal Marketing, Costs

Law360, New York (November 21, 2007, 12:00 AM EST) -- The State of Arkansas has filed a lawsuit against Johnson & Johnson and subsidiaries Janssen Pharamceutica Inc. and Janssen LP alleging the companies illegally promoted the antipsychotic drug, Risperdal, to doctors for unnecessary medical conditions at a cost to the state.

The lawsuit, filed Tuesday in the Circuit Court of Pulaski County in Arkansas, also alleges that the companies are misrepresenting the risks of the medication to patients.

The suit seeks to recover the money the state paid to provide Risperdal to patients through Medicaid and...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.